Se establece un Centro Colaborador de la OMS para la Reducción de Daños en la Universidad de Vilnius

El Centro Colaborador de la OMS para la Reducción de Daños se encargará de aplicar intervenciones basadas en pruebas empíricas en el marco de la respuesta al VIH en Europa. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

By the initiative of World Health Organization (WHO) the Collaborating Centre for Harm Reduction (WHO’s CC) has been established at the Vilnius University Public Health Institute (PHI) in the 2013.

“WHO’s designation of the PHI as the first Collaborating Centre on Harm Reduction reaffirms the importance of and our commitment to applying evidence-informed interventions when responding to HIV in the European Region”, says Martin Donoghoe, Programme Manager, HIV/AIDS, STIs & Viral Hepatitis for the WHO Regional Office for Europe.

WHO’s CC is the first such centre among more than 800 institutions in over 80 countries dedicated to strengthen the capacity building of stakeholders and research on harm reduction, also it has been launched with the support of Eurasian Harm Reduction Network (EHRN) and Vilnius Centre for Addictive Disorders.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.